Auto-injectors are devices designed to simplify the process of administering injectable pharmaceuticals at home. They are particularly useful for individuals who need to self-administer medication on ...

Auto-injector specialist Ypsomed is hopping on the U.S. manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the ...

If you or someone you love has an allergy that results in anaphylaxis, you know how important it is to administer epinephrine at the first sign of a reaction. Epinephrine is the frontline treatment ...

The approval of the interchangeable designation was supported by data from a randomized, double-blind phase 4 trial (ClinicalTrials.gov Identifier: NCT05510063) that assessed the pharmacokinetics, ...

When prescribing a biologic treatment, physicians have the opportunity to share what alternatives might be available to best suit their patient’s lifestyle, including affordability. (1) (Cedric ...

Samsung Bioepis and Organon shared that the Food and Drug Administration has designated the Hadlima (adalimumab-bwwd) high- and low-concentration (40 mg/0.4 ml, 40 mg/0.8 ml) autoinjectors and ...

The Food and Drug Administration (FDA) has designated Hadlima™ (adalimumab-bwwd) an interchangeable biosimilar to Humira ® (adalimumab). In the study, participants (N=371) were treated with Humira ...

The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands patient access in the process. Full interchangeability approved: The FDA has ...